Browse studies

Find your next paid study

21 recruiting studies matching your filters

A Phase I Randomized Controlled Trial of Intratumoral Lidocaine Injection Before Transoral Robotic Surgery (TORS) and Neck Dissection for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Based on evidence that the local anesthetic lidocaine may have anticancer effects, this study will assess the safety and efficacy of intratumoral lidocaine inj…

Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more

Estimated

~$10 – $7,500

Ryan CareyNCT06747390

Observational

The STOP-HPV Scale Up Study

Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm cl…

Human Papilloma Virus Vaccine

Estimated

~$10 – $6,250

University of California, Los AngelesNCT06831383

Phase 2

Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma

The purpose of this study is to find out if lower doses of radiation may help reduce the side effects of radiation therapy in combination with standard-of-care…

HPVThroat CancerOropharyngeal Carcinoma+2 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT05491512

Phase 2

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

The purpose of this Phase 2 study is to compare the effects of administering the PVX4 combination device biologic product (pBI-4 DNA vaccine via electroporatio…

Cervical Intraepithelial Neoplasia Grade 2/3Human Papilloma Virus Infection Type 16

Estimated

~$10 – $8,750

PapiVax Biotech, Inc.NCT07454915

PROGRESS: Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

In May 2018, the World Health Organization (WHO) launched a strategy to eliminate cervical cancer. While this strategy seeks to achieve coverage of 70% in dise…

Human Papilloma Virus

Estimated

~$10 – $1,050

Atila Biosystems Inc.NCT07232355

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

The goal of this study is to test two commercially available technologies for their ability to detect treatment response in patients with cervical cancer follo…

Cervical CancerHuman Papilloma Virus (HPV)

Estimated

~$10 – $750

University of FloridaNCT07214584

Phase 3

COVE-2: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-301; referred to as COVE-2 \[Cantharidin and Occlusion in Verruca Epi…

Common WartsCommon Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07246590

Phase 3

COVE-4: A Phase 3, Open-Label, Long-Term Follow-Up Study to Evaluate the Safety and Efficacy of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…

Common Warts (Verruca Vulgaris)Common WartsHuman Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07457918

Observational

Intervention to Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine Series

The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute …

Human Papilloma Virus

Estimated

~$10 – $6,250

University of Colorado, DenverNCT04611022